18324952

Source:http://linkedlifedata.com/resource/pubmed/id/18324952

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0392747, umls-concept:C0529351, umls-concept:C0878773, umls-concept:C1457887, umls-concept:C1554963, umls-concept:C1707455
pubmed:issue	4
pubmed:dateCreated	2008-3-7
pubmed:abstractText	This study assessed the benefit of adding behavioural modification to darifenacin treatment for overactive bladder (OAB).
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/18324952-10494113, http://linkedlifedata.com/resource/pubmed/commentcorrection/18324952-10798461, http://linkedlifedata.com/resource/pubmed/commentcorrection/18324952-11183901, http://linkedlifedata.com/resource/pubmed/commentcorrection/18324952-11857671, http://linkedlifedata.com/resource/pubmed/commentcorrection/18324952-12425706, http://linkedlifedata.com/resource/pubmed/commentcorrection/18324952-12425863, http://linkedlifedata.com/resource/pubmed/commentcorrection/18324952-12493360, http://linkedlifedata.com/resource/pubmed/commentcorrection/18324952-12507537, http://linkedlifedata.com/resource/pubmed/commentcorrection/18324952-12614251, http://linkedlifedata.com/resource/pubmed/commentcorrection/18324952-15013654, http://linkedlifedata.com/resource/pubmed/commentcorrection/18324952-15602011, http://linkedlifedata.com/resource/pubmed/commentcorrection/18324952-16925744, http://linkedlifedata.com/resource/pubmed/commentcorrection/18324952-2931042, http://linkedlifedata.com/resource/pubmed/commentcorrection/18324952-3403874, http://linkedlifedata.com/resource/pubmed/commentcorrection/18324952-7270599, http://linkedlifedata.com/resource/pubmed/commentcorrection/18324952-7775717
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9712381
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Benzofurans, http://linkedlifedata.com/resource/pubmed/chemical/Muscarinic Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Pyrrolidines, http://linkedlifedata.com/resource/pubmed/chemical/darifenacin
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	1742-1241
pubmed:author	pubmed-author:BeamerEE, pubmed-author:ChancellorM BMB, pubmed-author:DelconteAA, pubmed-author:EbingerUU, pubmed-author:HicksGG, pubmed-author:KianifardFF, pubmed-author:MongayLL
pubmed:issnType	Electronic
pubmed:volume	62
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	606-13
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:18324952-Adolescent, pubmed-meshheading:18324952-Adult, pubmed-meshheading:18324952-Aged, pubmed-meshheading:18324952-Behavior Therapy, pubmed-meshheading:18324952-Benzofurans, pubmed-meshheading:18324952-Combined Modality Therapy, pubmed-meshheading:18324952-Female, pubmed-meshheading:18324952-Humans, pubmed-meshheading:18324952-Male, pubmed-meshheading:18324952-Middle Aged, pubmed-meshheading:18324952-Muscarinic Antagonists, pubmed-meshheading:18324952-Pyrrolidines, pubmed-meshheading:18324952-Treatment Outcome, pubmed-meshheading:18324952-Urinary Bladder, Overactive
pubmed:year	2008
pubmed:articleTitle	A comparison of the efficacy of darifenacin alone vs. darifenacin plus a Behavioural Modification Programme upon the symptoms of overactive bladder.
pubmed:affiliation	Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. chancellormb@msx.upmc.edu
pubmed:publicationType	Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study